Morepen Labs shares gained 2.37% to ₹94.43 following the launch of its first prescription generic product, Desloratadine Tablets, in the US market through its subsidiary Morepen Bio Inc. The company…. Morepen shares rise 2.37% on US generic drug launch CompaniesMorepen shares rise 2.37% on US generic drug launch09 November 2026•2 min 42 sec readAdd as Preferred Source.